Pediatric Nephrology Ward with Dialysis Division for Children, Public Clinical Hospital No. 1, Zabrze, Poland.
Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
Int J Rheum Dis. 2020 Aug;23(9):1184-1193. doi: 10.1111/1756-185X.13904. Epub 2020 Jul 5.
The aim of this study was to investigate the clinical course, selected biochemical parameters and concentrations of renal injury biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1) and liver-fatty acid binding protein (L-FABP) in patients with immunoglobulin A vasculitis (IgAV) to identify the markers associated with nephritis in the course of the disease (IgAVN).
The study involved 29 children with IgAV and 34 healthy controls. Eleven (38%) patients had renal involvement (IgAV-N) and 18 (62%) did not exhibit nephritis (IgAV-noN). Initial laboratory tests, determining the concentrations of NGAL, KIM-1 and L-FABP in serum and urine, were conducted on children from the study group in an acute phase of IgAV as well as after an average of 6 months, during a follow-up visit. The interconnection between renal involvement, anthropometric measurements, epidemiological data, laboratory parameters and levels of examined biomarkers have been thoroughly evaluated.
The serum and urine levels of NGAL, KIM-1 and L-FABP were significantly higher in children with an acute phase of IgAV as compared to the control group (P < .001) and markedly lower during follow-up retesting in comparison with the values obtained at inclusion (P < .001). However, the concentration of none of the evaluated biomarkers correlated with nephrological indices. Among all examined parameters, only male subjects were associated with nephritis (P = .017).
We have established no evident association between the concentrations of NGAL, KIM-1 and L-FABP and nephritis in the course of IgAV in children. Additionally, we confirmed a significant male predominance in patients with nephritis.
本研究旨在探讨免疫球蛋白 A 血管炎(IgAV)患者的临床病程、选定生化参数以及中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、肾损伤分子-1(KIM-1)和肝型脂肪酸结合蛋白(L-FABP)等肾损伤生物标志物的浓度,以确定与疾病过程中肾炎相关的标志物(IgAVN)。
本研究纳入了 29 名 IgAV 患儿和 34 名健康对照者。11 名(38%)患儿存在肾脏受累(IgAV-N),18 名(62%)患儿无肾炎(IgAV-noN)。在 IgAV 的急性期以及平均 6 个月后的随访时,对研究组患儿进行了初始实验室检查,以确定血清和尿液中 NGAL、KIM-1 和 L-FABP 的浓度。我们全面评估了肾脏受累、人体测量学指标、流行病学数据、实验室参数和所检查生物标志物水平之间的相互关系。
与对照组相比,IgAV 急性期患儿的血清和尿液 NGAL、KIM-1 和 L-FABP 水平显著升高(P<.001),且在随访时的复测中明显低于纳入时的水平(P<.001)。然而,评估的生物标志物浓度与肾脏指标均无明显相关性。在所有检查的参数中,只有男性与肾炎有关(P=.017)。
我们未发现 NGAL、KIM-1 和 L-FABP 浓度与儿童 IgAV 病程中的肾炎之间存在明显关联。此外,我们证实了肾炎患者中男性占优势。